+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Increased microsomal triglyceride transfer protein (MTP) expression in the intestine but not the liver of diabetic rabbits



Increased microsomal triglyceride transfer protein (MTP) expression in the intestine but not the liver of diabetic rabbits



Diabetes Research and Clinical Practice 50: 378-379




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 062894909

Download citation: RISBibTeXText

DOI: 10.1016/s0168-8227(00)81292-9


Related references

Increased microsomal triglyceride transfer protein expression in the intestine but not the liver of diabetic rabbits. Diabetes Research & Clinical Practice 50(Suppl 1): S379, 2000

Increased microsomal triglyceride transfer protein in diabetic rabbits The cause of elevated postprandial apo B48-containing chylomicron S?. Diabetologia 43(Suppl. 1): A163, 2000

Hepatic expression of microsomal triglyceride transfer protein and in vivo secretion of triglyceride-rich lipoproteins are increased in obese diabetic mice. Diabetes 51(4): 1233-1239, 2002

Regulation of microsomal triglyceride transfer protein expression in newborn swine small intestine and liver. Journal of Investigative Medicine 49(1): 122A, 2001

Garlic inhibits microsomal triglyceride transfer protein gene expression in human liver and intestinal cell lines and in rat intestine. Journal of Nutrition 132(6): 1165-1168, 2002

Microsomal triglyceride transfer protein expression in mouse intestine. Histochemistry and Cell Biology 123(4-5): 475-482, 2005

Cardiac expression of microsomal triglyceride transfer protein is increased in obesity and serves to attenuate cardiac triglyceride accumulation. Plos one 4(4): E5300, 2009

Combination therapy of an intestine-specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator-activated receptor γ agonist in diabetic rat. Journal of Diabetes Research 2014: 890639, 2014

Intestinal microsomal triglyceride transfer protein in type 2 diabetic and non-diabetic subjects: the relationship to triglyceride-rich postprandial lipoprotein composition. Atherosclerosis 187(1): 57-64, 2006

JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, ameliorates impaired glucose and lipid metabolism in Zucker diabetic fatty rats. Diabetes Obesity and Metabolism 13(7): 629-638, 2011

JTT-130, a novel intestine-specific inhibitor of microsomal triglyceride transfer protein, improves hyperglycemia and dyslipidemia independent of suppression of food intake in diabetic rats. Journal of Diabetes Research 2014: 803832, 2014

Liver X receptor agonist modulation of cholesterol efflux in mice with intestine-specific deletion of microsomal triglyceride transfer protein. Arteriosclerosis Thrombosis and Vascular Biology 32(7): 1624-1631, 2012

Quantitative studies of microsomal triglyceride transfer protein and apolipoprotein B mRNA in human hearts reveal increased MTP and apoB gene expression in ischemic left ventricle and an association of MTP mRNA with triglyceride content. Circulation 102(18 Suppl.): II 147, 2000

Co-translational degradation of apolipoprotein B100 by the proteasome is prevented by microsomal triglyceride transfer protein. Synchronized translation studies on HepG2 cells treated with an inhibitor of microsomal triglyceride transfer protein. Journal of Biological Chemistry 272(33): 20435-20442, 1997

ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice. Journal of Lipid Research 49(9): 2013-2022, 2008